Voyager Therapeutics Balance Sheet (2014-2026)

Reported Financials

Voyager Therapeutics Quarterly Balance Sheet

Periods 49 quarters

Latest Sep 2026

Voyager Therapeutics reported total assets of $177.05M and total liabilities of $41.94M for the quarter ended Sep 2026, down 38.6% year over year. This balance sheet covers 49 quarters of results from Sep 2014 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	117.43M	131.87M	78.33M	96.86M	98.96M	268.32M	244.29M	65.27M	68.80M	143.08M	76.13M	112.53M	71.37M	74.76M	43.94M	45.13M	65.30M	43.31M	35.77M	48.41M
Short-term InvestmentsInvestments (Current)	15.11M	34.96M	69.73M	34.78M	19.89M	4.99M	28.45M	187.67M	162.07M	256.49M	294.89M	232.84M	195.32M	161.26M	171.65M	163.81M	131.15M	98.17M	80.57M	58.40M
Cash & Current Investments	132.54M	166.83M	148.06M	131.64M	118.85M	273.31M	272.75M	252.94M	230.88M	399.57M	371.02M	345.36M	266.68M	236.02M	215.59M	208.93M	196.45M	141.48M	116.34M	106.81M
Receivables - NetNet Receivables				10.00M		25.00M			80.15M	0.84M	1.70M	15.95M	1.50M	1.62M	1.67M	3.19M	1.76M	1.49M	2.93M	4.02M
Receivables - OtherOther Receivables	0.73M	0.21M	0.15M	0.23M	0.26M	0.33M	3.35M	3.25M	3.34M	2.62M	1.55M	3.71M	0.68M	0.49M	0.85M	0.85M	0.15M	0.15M	0.22M	0.26M
Receivables				10.23M		25.33M			83.49M	3.46M	3.25M	19.67M	2.18M	2.11M	2.53M	4.04M	1.91M	1.65M	3.15M	4.27M
Prepaid Assets	3.43M	3.61M	3.42M	5.08M	5.39M	3.98M	6.08M	5.74M	5.32M	6.11M	7.30M	8.42M	7.95M	7.08M	9.77M	6.62M	4.33M	3.86M	5.74M	3.35M
Current Assets	136.70M	170.65M	151.63M	146.94M	124.50M	302.63M	282.18M	261.93M	319.68M	409.14M	381.57M	373.44M	276.81M	245.21M	227.89M	219.59M	202.69M	146.98M	125.23M	114.43M
Non-Current Assets
Construction in Progress
Property, Plant & Equipment (Net)PP&E (Net)	21.92M	19.37M	19.07M	18.08M	17.86M	17.14M	17.24M	17.11M	16.49M	17.38M	16.27M	15.20M	14.31M	13.93M	13.92M	13.29M	13.14M	12.22M	11.19M	9.77M
Long-Term Investments	33.46M		16.39M	15.94M	15.49M		14.53M	14.03M		1.00M			65.70M	59.10M	46.45M	20.08M	5.24M	30.18M	32.48M	25.33M
Other Non-Current Assets	1.78M	1.78M	1.52M	1.52M	1.52M	1.52M	1.59M	1.59M	1.59M	2.89M	2.87M	2.87M	2.87M	2.87M	2.87M	5.61M	2.74M	2.74M	2.95M	2.95M
Non-Current Assets	57.16M	53.53M	36.98M	35.54M	34.86M	33.67M	33.36M	32.73M	31.60M	60.46M	54.66M	52.60M	116.24M	108.03M	94.21M	68.73M	49.59M	72.34M	72.53M	62.62M
Assets	193.86M	224.18M	188.61M	182.48M	159.36M	336.29M	315.54M	294.65M	351.28M	469.59M	436.23M	426.04M	393.05M	353.24M	322.10M	288.31M	252.28M	219.33M	197.75M	177.05M
Liabilities
Current Liabilities
Accounts Payables	0.57M	1.20M	1.22M	1.34M	2.57M	3.70M	1.66M	3.27M	1.60M	7.58M	2.61M	3.16M	4.00M	2.63M	1.80M	2.12M	5.01M	2.72M	1.61M	1.95M
Payables	0.57M	1.20M	1.22M	1.34M	2.57M	3.70M	1.66M	3.27M	1.60M	7.58M	2.61M	3.16M	4.00M	2.63M	1.80M	2.12M	5.01M	2.72M	1.61M	1.95M
Accumulated Expenses	10.95M	7.74M	7.19M	12.53M	7.82M	7.64M	9.06M	11.05M	16.82M	7.60M	10.27M	11.44M	14.17M	9.05M	12.03M	14.95M	12.10M	6.97M	7.95M	8.49M
Other Accumulated Expenses	5.57M	5.75M	2.53M	2.75M	2.83M	2.92M	3.01M	3.11M	3.20M	5.94M	6.74M	6.98M	1.20M				0.55M	0.51M	0.63M	0.40M
Current Deferred Revenue	33.89M	86.99M	87.00M	56.63M	59.38M	5.68M	31.67M	44.26M	42.88M	51.44M	20.52M	22.63M	24.39M	21.10M	20.52M	10.58M	1.59M	0.40M	0.24M
Total Current Liabilities	50.98M	101.68M	97.93M	73.24M	72.59M	19.94M	45.40M	61.69M	64.51M	72.55M	40.13M	44.21M	49.79M	40.21M	41.98M	35.50M	26.54M	17.45M	16.69M	16.81M
Non-Current Liabilities
Non-Current Deferred Revenue	8.21M	8.45M	7.88M	7.39M	6.45M	78.87M	51.38M	37.83M	32.36M	13.16M	19.47M	12.15M	6.00M	4.76M	2.61M	1.47M
Preferred Stock Liabilities
Operating Leases	38.61M	37.12M	21.74M	21.02M	20.29M	19.52M	18.73M	17.92M	17.09M	42.00M	40.21M	38.37M	36.50M	34.57M	32.57M	30.52M	28.66M	27.20M	25.69M	24.13M
Other Non-Current Liabilities	39.61M	38.13M	22.74M	22.02M	21.30M	20.52M	19.73M	18.92M	18.09M	43.00M	41.21M	39.37M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M	1.00M
Total Non-Current Liabilities	59.19M	110.13M	105.81M	80.63M	79.04M	98.81M	96.78M	99.51M	96.87M	85.71M	59.60M	56.36M	92.29M	79.54M	77.16M	67.49M	55.20M	44.66M	42.38M	40.94M
Total Liabilities	98.80M	148.25M	128.55M	102.66M	100.34M	119.33M	116.51M	118.43M	114.96M	128.71M	100.81M	95.73M	93.29M	80.54M	78.16M	68.49M	56.20M	45.66M	43.38M	41.94M
Shareholder's Equity
Common Equity	95.06M	75.93M	60.05M	79.82M	59.02M	216.96M	199.03M	176.22M	236.32M	340.89M	335.42M	330.31M	299.76M	272.70M	243.94M	219.83M	196.08M	173.67M	154.38M	135.11M
Liabilities and Shareholders Equity	193.86M	224.18M	188.61M	182.48M	159.36M	336.29M	315.54M	294.65M	351.28M	469.59M	436.23M	426.04M	393.05M	353.24M	322.10M	288.31M	252.28M	219.33M	197.75M	177.05M
Retained Earnings	-347.10M	-368.42M	-387.51M	-369.90M	-393.51M	-269.50M	-291.70M	-317.60M	-261.18M	-272.51M	-282.70M	-291.70M	-326.18M	-357.21M	-390.60M	-418.50M	-445.91M	-473.84M	-498.32M	-523.01M

Voyager Therapeutics Balance Sheet API

Pull Voyager Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VYGR&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "VYGR", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=VYGR&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Voyager Therapeutics VYGR Balance Sheet (2014-2026)

Voyager Therapeutics Quarterly Balance Sheet

Voyager Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password